» Articles » PMID: 36499517

Age-Related Decline in Nrf2/ARE Signaling Is Associated with the Mitochondrial DNA Damage and Cognitive Impairments

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2022 Dec 11
PMID 36499517
Authors
Affiliations
Soon will be listed here.
Abstract

In this research, we compared the cognitive parameters of 2-, 7-, and 15-month-old mice, changes in mitochondrial DNA (mtDNA) integrity and expression of genes involved in the nuclear erythroid 2-related factor 2/antioxidant response element (Nrf2/ARE) signaling pathway. We showed an age-related decrease in the expression in the cerebral cortex, not in the hippocampus. At the same time, we find an increase in the mtDNA copy number in the cerebral cortex, despite the lack of an increase in gene expression, which is involved in the mitochondrial biogenesis regulation. We suppose that increase in mtDNA content is associated with mitophagy downregulation. We supposed that mitophagy downregulation may be associated with an age-related increase in the mtDNA damage. In the hippocampus, we found a decrease in the expression, which is involved in the pathways, which play an essential role in regulating long-term memory formation. We showed a deficit of working and reference memory in 15-month-old-mice in the water Morris maze, and a decrease in the exploratory behavior in the open field test. Cognitive impairments in 15-month-old mice correlated with a decrease in expression in the hippocampus, expression, and an increase in the number of mtDNA damage in the cerebral cortex. Thus, these signaling pathways may be perspective targets for pharmacological intervention to maintain mitochondrial quality control, neuronal plasticity, and prevent the development of age-related cognitive impairment.

Citing Articles

Inflammasomes in Alzheimer's Progression: Nrf2 as a Preventive Target.

Lopez-Hernandez R, de la Torre-Alamo M, Garcia-Bueno B, Baroja-Mazo A, Fenoy F, Cuevas S Antioxidants (Basel). 2025; 14(2).

PMID: 40002308 PMC: 11851705. DOI: 10.3390/antiox14020121.


Reinforcing Nrf2 Signaling: Help in the Alzheimer's Disease Context.

la Torre A, Lo Vecchio F, Angelillis V, Gravina C, DOnofrio G, Greco A Int J Mol Sci. 2025; 26(3).

PMID: 39940900 PMC: 11818887. DOI: 10.3390/ijms26031130.


Proteostasis Decline and Redox Imbalance in Age-Related Diseases: The Therapeutic Potential of NRF2.

Buttari B, Tramutola A, Rojo A, Chondrogianni N, Saha S, Berry A Biomolecules. 2025; 15(1).

PMID: 39858508 PMC: 11764413. DOI: 10.3390/biom15010113.


Role of NRF2 in Pathogenesis of Alzheimer's Disease.

Chu C, Uruno A, Katsuoka F, Yamamoto M Antioxidants (Basel). 2025; 13(12.

PMID: 39765857 PMC: 11727090. DOI: 10.3390/antiox13121529.


Mitochondrial Dysfunction in Parkinson's Disease: A Contribution to Cognitive Impairment?.

Scorziello A, Sirabella R, Sisalli M, Tufano M, Giaccio L, DApolito E Int J Mol Sci. 2024; 25(21).

PMID: 39519043 PMC: 11546611. DOI: 10.3390/ijms252111490.


References
1.
Van Bulck M, Sierra-Magro A, Alarcon-Gil J, Perez-Castillo A, Morales-Garcia J . Novel Approaches for the Treatment of Alzheimer's and Parkinson's Disease. Int J Mol Sci. 2019; 20(3). PMC: 6386829. DOI: 10.3390/ijms20030719. View

2.
Hasegawa I, Hayashi T, Miyashita Y . Memory retrieval under the control of the prefrontal cortex. Ann Med. 2000; 31(6):380-7. DOI: 10.3109/07853899908998795. View

3.
Genova M, Bovina C, Marchetti M, Pallotti F, TIETZ C, Biagini G . Decrease of rotenone inhibition is a sensitive parameter of complex I damage in brain non-synaptic mitochondria of aged rats. FEBS Lett. 1997; 410(2-3):467-9. DOI: 10.1016/s0014-5793(97)00638-8. View

4.
Gureev A, Shaforostova E, Popov V . Regulation of Mitochondrial Biogenesis as a Way for Active Longevity: Interaction Between the Nrf2 and PGC-1α Signaling Pathways. Front Genet. 2019; 10:435. PMC: 6527603. DOI: 10.3389/fgene.2019.00435. View

5.
Cardozo-Pelaez F, Song S, Parthasarathy A, HAZZI C, Naidu K, Sanchez-Ramos J . Oxidative DNA damage in the aging mouse brain. Mov Disord. 1999; 14(6):972-80. DOI: 10.1002/1531-8257(199911)14:6<972::aid-mds1010>3.0.co;2-0. View